ES2045075T3 - Procedimiento para la preparacion de proteinas de plasmodium falciparum. - Google Patents

Procedimiento para la preparacion de proteinas de plasmodium falciparum.

Info

Publication number
ES2045075T3
ES2045075T3 ES88121299T ES88121299T ES2045075T3 ES 2045075 T3 ES2045075 T3 ES 2045075T3 ES 88121299 T ES88121299 T ES 88121299T ES 88121299 T ES88121299 T ES 88121299T ES 2045075 T3 ES2045075 T3 ES 2045075T3
Authority
ES
Spain
Prior art keywords
procedure
preparation
plasmodium falciparum
dna sequences
falciparum proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88121299T
Other languages
English (en)
Spanish (es)
Inventor
Bernhard Dr Knapp
Erika Dr Hundt
Burkhard Dr Enders
Hans Dr Kupper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2045075T3 publication Critical patent/ES2045075T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES88121299T 1987-12-30 1988-12-20 Procedimiento para la preparacion de proteinas de plasmodium falciparum. Expired - Lifetime ES2045075T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3744495 1987-12-30
DE3831351A DE3831351A1 (de) 1987-12-30 1988-09-15 Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung

Publications (1)

Publication Number Publication Date
ES2045075T3 true ES2045075T3 (es) 1994-01-16

Family

ID=25863316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88121299T Expired - Lifetime ES2045075T3 (es) 1987-12-30 1988-12-20 Procedimiento para la preparacion de proteinas de plasmodium falciparum.

Country Status (11)

Country Link
EP (1) EP0322712B1 (enExample)
JP (2) JPH022356A (enExample)
AU (1) AU625315B2 (enExample)
DE (2) DE3831351A1 (enExample)
DK (1) DK727688A (enExample)
ES (1) ES2045075T3 (enExample)
FI (1) FI99144C (enExample)
GR (1) GR3007126T3 (enExample)
IL (1) IL88818A (enExample)
PT (1) PT89363B (enExample)
YU (1) YU48126B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4041836A1 (de) * 1990-12-24 1992-06-25 Behringwerke Ag Protektive plasmodium falciparum hybridproteine, die teilsequenzen der malaria-antigene hrpii und serp enthalten, ihre herstellung und verwendung
WO1994003604A1 (en) * 1992-08-07 1994-02-17 Schering Corporation PfEMP3 MALARIA ANTIGEN, ANALOGS, ANTIBODIES AND USES THEREOF
US6350933B1 (en) * 1997-01-10 2002-02-26 The Regents Of The University Of California RG polynucleotides for conferring powdery mildew resistance in plants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25993A (en) * 1984-02-22 1992-01-13 Wellcome Found Cloning of DNA for protozoal antigens
EP0309746A1 (de) * 1987-09-08 1989-04-05 F. Hoffmann-La Roche Ag Antimalaria-Vakzine

Also Published As

Publication number Publication date
FI99144C (fi) 1997-10-10
FI886001L (fi) 1989-07-01
JPH11318475A (ja) 1999-11-24
EP0322712A3 (en) 1990-05-02
IL88818A (en) 1997-02-18
AU2761988A (en) 1989-07-06
IL88818A0 (en) 1989-07-31
AU625315B2 (en) 1992-07-09
FI99144B (fi) 1997-06-30
DE3831351A1 (de) 1989-07-13
PT89363B (pt) 1993-08-31
PT89363A (pt) 1989-12-29
EP0322712A2 (de) 1989-07-05
JPH022356A (ja) 1990-01-08
YU48126B (sh) 1997-05-28
DK727688A (da) 1989-07-01
EP0322712B1 (de) 1992-11-25
DK727688D0 (da) 1988-12-29
GR3007126T3 (enExample) 1993-07-30
DE3876227D1 (de) 1993-01-07
YU237588A (en) 1991-06-30

Similar Documents

Publication Publication Date Title
ES2164794T3 (es) Dna que codifica cd 19.
IT1156461B (it) Procedimento per la produzione di dna complementare rappresentante sequenze virali di rna mediante metodi del dna ricombinante prodotti relativi e loro usi
DK511381A (da) Mucopolysaccaharider som har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
ES2181689T3 (es) Variantes del factor de crecimiento de hepatocitos.
ES2058566T3 (es) Sondas de hibridacion para detectar las cepas de neisseria.
IT1203851B (it) Espressione e purificazione di una gene proteina htlv-iii gag/env
FI881363L (fi) Konstgjord hud.
ES8900007A1 (es) Un metodo para producir normas orales frente a virus de hepatitis-b.
ES2530769T3 (es) Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno
AU592749B2 (en) Cloning of dna for protozoal antigens
ES8602133A1 (es) Un procedimiento para preparar un vector de transferencias de adn
MX9307465A (es) Proteinas que tienen actividad de transferasa glicosilica.
ES2104596T3 (es) Nuevos polipeptidos, secuencias de adn que permiten su expresion, metodo de preparacion, y utilizacion.
ES2058486T3 (es) Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis.
FI896242A7 (fi) HIV-ENV-proteiineihin liittyviä synteettisiä peptidejä
DK656588D0 (da) Substituerede hydroxylaminer, deres fremstilling og anvendelse som laegemidler, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
DE3782560D1 (de) Hefestaemme zur expression fremder gene.
CY1105331T1 (el) Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
IT8222411A0 (it) Procedimento per la produzione di interferone da geni umani.
DE69929683D1 (de) Antisense modulierung von lfa-3
MY104975A (en) Protease, reverse transcriptase and endonuclease of retrovirus, and method for producing these enzymes.
ES2061655T3 (es) Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos.
MX14385A (es) Proteinas con secuencias de adn especificas para malaria, sus productos de expresion y su empleo y procedimiento para la preparacion de las mismas
DE69636737D1 (de) Neues immunoregulatorisches protein lst-1

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 322712

Country of ref document: ES